DI 23022: Processing Quick Disability Determination (QDD) and Compassionate Allowances (CAL) in the Disability Determination Services (DDS)
TN 3 (02-10)
ALSTROM SYNDROME | ||
ALTERNATE NAMES |
ALMS; ALMS1; Alstrom-Halgren Syndrome; Alstrom syndrome 1 |
|
DESCRIPTION |
Alstrom Syndrome (ALMS) is a rare genetic condition that results from a mutation of the ALMS1 gene. The condition affects multiple body systems. ALMS is characterized by:
This disorder can also cause serious or life-threatening medical problems involving the liver, bladder, and lungs. The signs and symptoms of ALMS vary in severity and may begin in infancy or early childhood, although some appear later in life. Some children may experience delays in attaining developmental milestones, but intelligence is usually unaffected. Not all affected individuals have all of the characteristic features of the disorder. |
|
DIAGNOSTIC TESTING, PHYSICAL FINDINGS, AND ICD-9-CM CODING |
The diagnosis is usually made clinically. Genetic testing can identify mutations in the ALMS1 gene in both parents. Other diagnostic tests include:
Documentation of developmental delays may be helpful. ICD-9: 759.89 (Other specified congenital anomalies) |
|
ONSET AND PROGRESSION |
Individuals with ALMS are likely to develop:
|
|
TREATMENT |
There is no cure for this condition. There is treatment for the symptoms of diabetes, hearing and visual aids, heart medications, and thyroid hormone replacement. |
|
SUGGESTED PROGRAMMATIC ASSESSMENT* | ||
Suggested MER for Evaluation: Clinical examination, blood and urine tests, thyroid function studies, eye examinations and hearing examinations, and genetic testing. | ||
Suggested Listings for Evaluation: | ||
DETERMINATION |
LISTING |
REMARKS |
Meets Listing |
110.08 B |
|
Medical Equals |
* Adjudicators may, at their discretion, use the Medical Evidence of Record or Listings suggested to evaluate the claim. However, the decision to allow or deny the claim rests with the adjudicator.